What is Rhythm Pharmaceuticals, Inc.'s investment purchases?

Rhythm Pharmaceuticals, Inc. (RYTM) reported investment purchases of $42.2M in Q1 2026.

How has Rhythm Pharmaceuticals, Inc.'s investment purchases changed year-over-year?

Rhythm Pharmaceuticals, Inc.'s investment purchases increased by 25.9% year-over-year, from $33.52M to $42.2M.

What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s investment purchases?

Over 3 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s investment purchases has grown at a -12.8% compound annual growth rate (CAGR), from $524.97M to $348.67M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

Rhythm Pharmaceuticals, Inc. RYTM Investment Purchases

Investment Purchases at other companies

Eli LillyLLY

$297M+50.8%

Arrowhead ResearchARWR

$924.64M+43.5%

Praxis Precision Medicines, Inc.PRAX

$486.78M+316%

BridgeBio PharmaBBIO

$52.67M—

Neurocrine BiosciencesNBIX

$819.5M+200%

Mirum Pharmaceuticals, Inc.MIRM

——

Other financials

Income statement

See full

Revenue$60.1M+83.8%

Gross profit$53.0M+82.3%

Operating income-$52.4M-11.4%

Net income-$55.6M-12.4%

EPS (diluted)-$0.83-2.5%

Balance sheet

See full

Cash & equivalents$62.1M-41.4%

Total debt$112.3M-1.1%

Total equity$122.9M+549%

Total assets$442.3M+14.4%

Cash flow

See full

Operating cash flow-$44.2M-9.5%

CapEx$238.3K—

Free cash flow-$29.2M-2.4%

Valuation

See full

Market cap$6.64B+77.3%

Enterprise value$6.69B+78.4%

P/S30.6×+3.2×

Profitability

See full

Gross margin89.4%-0.2pp

Operating margin-90.9%-19.8pp

Net margin-93.3%-18.2pp

FCF margin-61.5%-14.1pp

Returns & leverage

See full

Return on equity-285.8%-68.9pp

Debt / equity0.9×-5.1×

Current ratio4.2×+0.9×

Where this comes from

Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s investment purchases?: Rhythm Pharmaceuticals, Inc. (RYTM) reported investment purchases of $42.2M in Q1 2026.
How has Rhythm Pharmaceuticals, Inc.'s investment purchases changed year-over-year?: Rhythm Pharmaceuticals, Inc.'s investment purchases increased by 25.9% year-over-year, from $33.52M to $42.2M.
What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s investment purchases?: Over 3 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s investment purchases has grown at a -12.8% compound annual growth rate (CAGR), from $524.97M to $348.67M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.